CD44 and prostate neoplasm: To verify that CXCR4 expression is upregulated in prostate tumor initiating cells, we examined CXCR4 levels in CD44+/CD133+ prostate cancer progenitor cells and total cell populations in the DU145 and PC3 cell lines by flow cytometry.